{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:55:58Z","timestamp":1790985358141,"version":"4.1.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s00228-026-04194-5","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:45:01Z","timestamp":1790984701000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quercetin as a modulator of xenobiotic metabolism: integrating CYP450 regulation, phase II conjugation pathways, and transporter-mediated drug interactions"],"prefix":"10.1007","volume":"82","author":[{"given":"Seerwan Hamadameen","family":"Sulaiman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3774-6071","authenticated-orcid":false,"given":"Rebaz Anwar","family":"Omer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hunar Yasin","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amjad Mahmood","family":"Qadir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemn A.H.","family":"Barzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,3]]},"reference":[{"key":"4194_CR1","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.nutres.2004.07.005","volume":"24","author":"I Erlund","year":"2004","unstructured":"Erlund I (2004) Review of the flavonoids quercetin, hesperetin, and naringenin. Dietary sources, bioactivities, bioavailability, and epidemiology. Nutr Res 24:851\u2013874. https:\/\/doi.org\/10.1016\/j.nutres.2004.07.005","journal-title":"Nutr Res"},{"key":"4194_CR2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.tiv.2005.06.048","volume":"20","author":"YJ Moon","year":"2006","unstructured":"Moon YJ, Wang X, Morris ME (2006) Dietary flavonoids: effects on xenobiotic and carcinogen metabolism. Toxicol Vitro 20:187\u2013210. https:\/\/doi.org\/10.1016\/j.tiv.2005.06.048","journal-title":"Toxicol Vitro"},{"key":"4194_CR3","doi-asserted-by":"publisher","first-page":"e32422","DOI":"10.1016\/j.heliyon.2024.e33342","volume":"10","author":"A Vollmannov\u00e1","year":"2024","unstructured":"Vollmannov\u00e1 A et al (2024) Quercetin as one of the most abundant represented biological valuable plant components with remarkable chemoprotective effects\u2014a review. Heliyon 10:e32422. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33342","journal-title":"Heliyon"},{"key":"4194_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S0003-9861(03)00284-4","volume":"417","author":"K Murota","year":"2003","unstructured":"Murota K, Terao J (2003) Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism. Arch Biochem Biophys 417:12\u201317. https:\/\/doi.org\/10.1016\/S0003-9861(03)00284-4","journal-title":"Arch Biochem Biophys"},{"key":"4194_CR5","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1002\/ptr.5220","volume":"28","author":"H Rastogi","year":"2014","unstructured":"Rastogi H, Jana S (2014) Evaluation of inhibitory effects of caffeic acid and quercetin on human liver cytochrome P450 activities. Phytother Res 28:1873\u20131878. https:\/\/doi.org\/10.1002\/ptr.5220","journal-title":"Phytother Res"},{"key":"4194_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.tox.2017.02.012","volume":"381","author":"J \u00d6stlund","year":"2017","unstructured":"\u00d6stlund J, Zlabek V, Zamaratskaia G (2017) In vitro inhibition of human CYP2E1 and CYP3A by quercetin and myricetin in hepatic microsomes is not gender dependent. Toxicology 381:10\u201318. https:\/\/doi.org\/10.1016\/j.tox.2017.02.012","journal-title":"Toxicology"},{"key":"4194_CR7","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3892\/etm.2021.10274","volume":"22","author":"R Zhang","year":"2021","unstructured":"Zhang R, Wei Y, Yang T, Huang X, Zhou J, Yang C, Zhou J, Liu Y, Shi S (2021) Inhibitory effects of quercetin and its major metabolite quercetin-3-O-\u03b2-D-glucoside on human UDP-glucuronosyltransferase 1A isoforms by liquid chromatography-tandem mass spectrometry. Exp Ther Med 22:842. https:\/\/doi.org\/10.3892\/etm.2021.10274","journal-title":"Exp Ther Med"},{"key":"4194_CR8","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.3390\/nu12082306","volume":"12","author":"V Mohos","year":"2020","unstructured":"Mohos V, Flisz\u00e1r-Ny\u00fal E, Ungv\u00e1ri O, Kuffa K, Needs PW, Kroon PA, Telbisz \u00c1, \u00d6zvegy-Laczka C, Po\u00f3r M (2020) Inhibitory effects of quercetin and its main methyl, sulfate, and glucuronic acid conjugates on cytochrome P450 enzymes, and on OATP, BCRP and MRP2 transporters. Nutrients 12:2306. https:\/\/doi.org\/10.3390\/nu12082306","journal-title":"Nutrients"},{"key":"4194_CR9","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/j.1365-2125.2011.04150.x","volume":"73","author":"LX Wu","year":"2012","unstructured":"Wu LX, Guo CX, Chen WQ, Yu J, Qu Q, Chen Y, Tan ZR, Wang G, Fan L, Li Q, Zhang W, Zhou HH (2012) Inhibition of the organic anion-transporting polypeptide 1B1 by quercetin: an in vitro and in vivo assessment. Br J Clin Pharmacol 73:750\u2013757. https:\/\/doi.org\/10.1111\/j.1365-2125.2011.04150.x","journal-title":"Br J Clin Pharmacol"},{"key":"4194_CR10","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.1003172","author":"MC Jihwaprani","year":"2023","unstructured":"Jihwaprani MC, Rizky WC, Mushtaq M (2023) Pharmacokinetics of quercetin. Quercetin\u2014Effects Hum Health IntechOpen. https:\/\/doi.org\/10.5772\/intechopen.1003172","journal-title":"Quercetin\u2014Effects Hum Health IntechOpen"},{"key":"4194_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/biom15010151","volume":"15","author":"HOA Alharbi","year":"2025","unstructured":"Alharbi HOA, Alshebremi M, Babiker AY, Rahmani AH (2025) The role of quercetin, a flavonoid in the management of pathogenesis through regulation of oxidative stress, inflammation, and biological activities. Biomolecules 15:151. https:\/\/doi.org\/10.3390\/biom15010151","journal-title":"Biomolecules"},{"key":"4194_CR12","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1177\/00912700122010366","volume":"41","author":"EU Graefe","year":"2001","unstructured":"Graefe EU, Wittig J, Mueller S, Riethling AK, Uehleke B, Drewelow B, Pforte H, Jacobasch G, Derendorf H, Veit M (2001) Pharmacokinetics and bioavailability of quercetin glycosides in humans. J Clin Pharmacol 41:492\u2013499. https:\/\/doi.org\/10.1177\/00912700122010366","journal-title":"J Clin Pharmacol"},{"key":"4194_CR13","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1111\/1541-4337.12351","volume":"17","author":"G Williamson","year":"2018","unstructured":"Williamson G, Kay CD, Crozier A (2018) The bioavailability, transport, and bioactivity of dietary flavonoids: a review from a historical perspective. Compr Rev Food Sci Food Saf 17:1054\u20131112. https:\/\/doi.org\/10.1111\/1541-4337.12351","journal-title":"Compr Rev Food Sci Food Saf"},{"key":"4194_CR14","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.3390\/ph16111631","volume":"16","author":"MA Mirza","year":"2023","unstructured":"Mirza MA, Mahmood S, Hilles AR, Ali A, Khan MZ, Zaidi SAA, Iqbal Z, Ge Y (2023) Quercetin as a therapeutic product: evaluation of its pharmacological action and clinical applications\u2014a review. Pharmaceuticals (Basel) 16:1631. https:\/\/doi.org\/10.3390\/ph16111631","journal-title":"Pharmaceuticals (Basel)"},{"key":"4194_CR15","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/fft2.50","volume":"1","author":"Y Hai","year":"2020","unstructured":"Hai Y, Zhang Y, Liang Y, Ma X, Qi X, Xiao J, Xue W, Luo Y, Yue T (2020) Advance on the absorption, metabolism, and efficacy exertion of quercetin and its important derivatives. Food Front 1:420\u2013434. https:\/\/doi.org\/10.1002\/fft2.50","journal-title":"Food Front"},{"key":"4194_CR16","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1080\/10715760100301441","volume":"35","author":"AJ Day","year":"2001","unstructured":"Day AJ, Mellon F, Barron D, Sarrazin G, Morgan MRA, Williamson G (2001) Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin. Free Radic Res 35:941\u2013952. https:\/\/doi.org\/10.1080\/10715760100301441","journal-title":"Free Radic Res"},{"key":"4194_CR17","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1093\/jn\/131.7.1938","volume":"131","author":"ALA Sesink","year":"2001","unstructured":"Sesink ALA, O\u2019Leary KA, Hollman PCH (2001) Quercetin glucuronides but not glucosides are present in human plasma after consumption of quercetin-3-glucoside or quercetin-4\u2032-glucoside. J Nutr 131:1938\u20131941. https:\/\/doi.org\/10.1093\/jn\/131.7.1938","journal-title":"J Nutr"},{"key":"4194_CR18","first-page":"407","volume":"58","author":"M Materska","year":"2008","unstructured":"Materska M (2008) Quercetin and its derivatives: chemical structure and bioactivity\u2014a review. Pol J Food Nutr Sci 58:407\u2013413","journal-title":"Pol J Food Nutr Sci"},{"key":"4194_CR19","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3390\/foods9030374","volume":"9","author":"GES Batiha","year":"2020","unstructured":"Batiha GES, Beshbishy AM, Ikram M, Mulla ZS, Abd El-Hack ME, Taha AE, Algammal AM, Elewa YHA (2020) The pharmacological activity, biochemical properties, and pharmacokinetics of the major natural polyphenolic flavonoid: quercetin. Foods 9:374. https:\/\/doi.org\/10.3390\/foods9030374","journal-title":"Foods"},{"key":"4194_CR20","unstructured":"Vijay PS (2025) Enhancement of bioavailability of quercetin and naringin using probiotic and vitamin-A: pharmacokinetic profiling and neuroprotective efficacy in an ICV-STZ induced Alzheimer\u2019s disease model. Dissertation, Gujarat Technological University"},{"key":"4194_CR21","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s43450-022-00347-6","volume":"33","author":"K Ding","year":"2023","unstructured":"Ding K, Jia H, Jiang W, Qin Y, Wang Y, Lei M (2023) A double-edged sword: focusing on potential drug-to-drug interactions of quercetin. Rev Bras Farmacogn 33:502\u2013513. https:\/\/doi.org\/10.1007\/s43450-022-00347-6","journal-title":"Rev Bras Farmacogn"},{"key":"4194_CR22","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s00228-009-0627-6","volume":"65","author":"KA Kim","year":"2009","unstructured":"Kim KA, Park PW, Park JY (2009) Short-term effect of quercetin on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein, in healthy volunteers. Eur J Clin Pharmacol 65:609\u2013614. https:\/\/doi.org\/10.1007\/s00228-009-0627-6","journal-title":"Eur J Clin Pharmacol"},{"key":"4194_CR23","doi-asserted-by":"publisher","first-page":"6169","DOI":"10.1080\/10408398.2021.1898333","volume":"62","author":"A Naeem","year":"2022","unstructured":"Naeem A, Ming Y, Pengyi H, Yong Jie K, Yali L, Haiyan Z, Shuai X, Wenjing L, Ling W, Ming Xia Z, Shan Shan L, Qin Z (2022) The fate of flavonoids after oral administration: a comprehensive overview of its bioavailability. Crit Rev Food Sci Nutr 62:6169\u20136186. https:\/\/doi.org\/10.1080\/10408398.2021.1898333","journal-title":"Crit Rev Food Sci Nutr"},{"key":"4194_CR24","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1089\/jmf.2021.K.0003","volume":"24","author":"VL Truong","year":"2021","unstructured":"Truong VL, Jun M, Jeong WS (2021) Phytochemical and over-the-counter drug interactions: involvement of phase I and II drug-metabolizing enzymes and phase III transporters. J Med Food 24:786\u2013805. https:\/\/doi.org\/10.1089\/jmf.2021.K.0003","journal-title":"J Med Food"},{"key":"4194_CR25","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1186\/1556-276X-9-684","volume":"9","author":"L Dian","year":"2014","unstructured":"Dian L, Yu E, Chen X, Wen X, Zhang Z, Qin L, Wang Q, Li G, Wu C (2014) Enhancing oral bioavailability of quercetin using novel soluplus polymeric micelles. Nanoscale Res Lett 9:684. https:\/\/doi.org\/10.1186\/1556-276X-9-684","journal-title":"Nanoscale Res Lett"},{"key":"4194_CR26","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1002\/jps.20325","volume":"94","author":"Y Zheng","year":"2005","unstructured":"Zheng Y, Haworth IS, Zuo Z, Chow MSS, Chow AHL (2005) Physicochemical and structural characterization of quercetin-\u03b2-cyclodextrin complexes. J Pharm Sci 94:1079\u20131089. https:\/\/doi.org\/10.1002\/jps.20325","journal-title":"J Pharm Sci"},{"key":"4194_CR27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ijpharm.2016.07.008","volume":"511","author":"TF Kellici","year":"2016","unstructured":"Kellici TF, Chatziathanasiadou MV, Diamantis D, Chatzikonstantinou AV, Andreadelis I, Christodoulou E, Valsami G, Mavromoustakos T, Tzakos AG (2016) Mapping the interactions and bioactivity of quercetin-(2-hydroxypropyl)-\u03b2-cyclodextrin complex. Int J Pharm 511:303\u2013311. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.07.008","journal-title":"Int J Pharm"},{"key":"4194_CR28","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0006-2952(02)01510-1","volume":"65","author":"KA O\u2019Leary","year":"2003","unstructured":"O\u2019Leary KA, Day AJ, Needs PW, Mellon FA, O\u2019Brien NM, Williamson G (2003) Metabolism of quercetin-7- and quercetin-3-glucuronides by an in vitro hepatic model: the role of human \u03b2-glucuronidase, sulfotransferase, catechol-O-methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism. Biochem Pharmacol 65:479\u2013491. https:\/\/doi.org\/10.1016\/S0006-2952(02)01510-1","journal-title":"Biochem Pharmacol"},{"key":"4194_CR29","doi-asserted-by":"publisher","first-page":"230S","DOI":"10.1093\/ajcn\/81.1.230S","volume":"81","author":"C Manach","year":"2005","unstructured":"Manach C, Williamson G, Morand C, Scalbert A, R\u00e9m\u00e9sy C (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81:230S\u2013242S. https:\/\/doi.org\/10.1093\/ajcn\/81.1.230S","journal-title":"Am J Clin Nutr"},{"key":"4194_CR30","doi-asserted-by":"publisher","unstructured":"Gonz\u00e1lez-Sarr\u00edas A, Tom\u00e1s-Barber\u00e1n FA, Garc\u00eda-Villalba R (2020) Structural diversity of polyphenols and distribution in foods. In: Tom\u00e1s-Barber\u00e1n FA, Gonz\u00e1lez-Sarr\u00edas A, Garc\u00eda-Villalba R (eds) Dietary polyphenols: their metabolism and health effects. Wiley, pp 1\u201329. https:\/\/doi.org\/10.1002\/9781119563754.ch1","DOI":"10.1002\/9781119563754.ch1"},{"key":"4194_CR31","doi-asserted-by":"publisher","first-page":"H2597","DOI":"10.1111\/1750-3841.13079","volume":"80","author":"Y Kashino","year":"2015","unstructured":"Kashino Y, Murota K, Matsuda N, Tomotake M, Hamano T, Mukai R, Terao J (2015) Effect of processed onions on the plasma concentration of quercetin in rats and humans. J Food Sci 80:H2597\u2013H2602. https:\/\/doi.org\/10.1111\/1750-3841.13079","journal-title":"J Food Sci"},{"key":"4194_CR32","doi-asserted-by":"publisher","first-page":"6421","DOI":"10.1080\/10408398.2021.1901650","volume":"62","author":"F Shahidi","year":"2022","unstructured":"Shahidi F, Pan Y (2022) Influence of food matrix and food processing on the chemical interaction and bioaccessibility of dietary phytochemicals: a review. Crit Rev Food Sci Nutr 62:6421\u20136445. https:\/\/doi.org\/10.1080\/10408398.2021.1901650","journal-title":"Crit Rev Food Sci Nutr"},{"key":"4194_CR33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00228-017-2345-9","volume":"74","author":"SK Bedada","year":"2018","unstructured":"Bedada SK, Neerati P (2018) The effect of quercetin on the pharmacokinetics of chlorzoxazone, a CYP2E1 substrate, in healthy subjects. Eur J Clin Pharmacol 74:91\u201397. https:\/\/doi.org\/10.1007\/s00228-017-2345-9","journal-title":"Eur J Clin Pharmacol"},{"key":"4194_CR34","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.3390\/nu18101483","volume":"18","author":"L Mosca","year":"2026","unstructured":"Mosca L, Pagano C, Tafuri MG, Di Maio G, Rejano-Gordillo CM, Della Marca R, D\u2019Angelo S, Monda M, Messina G, Polito R, Perrone P (2026) The gut microbiota\u2013polyphenol\u2013NLRP3 inflammasome axis: a key regulatory network linking diet to chronic inflammation. Nutrients 18:1483. https:\/\/doi.org\/10.3390\/nu18101483","journal-title":"Nutrients"},{"key":"4194_CR35","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1124\/dmd.31.5.533","volume":"31","author":"JL Raucy","year":"2003","unstructured":"Raucy JL (2003) Regulation of CYP3A4 expression in human hepatocytes by pharmaceuticals and natural products. Drug Metab Dispos 31:533\u2013539. https:\/\/doi.org\/10.1124\/dmd.31.5.533","journal-title":"Drug Metab Dispos"},{"key":"4194_CR36","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1042\/bj3400715","volume":"340","author":"HP Ciolino","year":"1999","unstructured":"Ciolino HP, Daschner PJ, Yeh GC (1999) Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. Biochem J 340:715\u2013722. https:\/\/doi.org\/10.1042\/bj3400715","journal-title":"Biochem J"},{"key":"4194_CR37","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1080\/10408398.2023.2299329","volume":"65","author":"G Williamson","year":"2025","unstructured":"Williamson G, Clifford MN (2025) A critical examination of human data for the biological activity of quercetin and its phase-2 conjugates. Crit Rev Food Sci Nutr 65:1669\u20131705. https:\/\/doi.org\/10.1080\/10408398.2023.2299329","journal-title":"Crit Rev Food Sci Nutr"},{"key":"4194_CR38","doi-asserted-by":"publisher","unstructured":"Murota K (2026) Bioavailability and metabolism of quercetin and its derivatives. Functional Food Factors. Springer, pp 297\u2013306. https:\/\/doi.org\/10.1007\/978-981-95-7068-3_34","DOI":"10.1007\/978-981-95-7068-3_34"},{"key":"4194_CR39","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1080\/00498250110119108","volume":"32","author":"C De Santi","year":"2002","unstructured":"De Santi C, Pietrabissa A, Mosca F, Rane A, Pacifici GM (2002) Inhibition of phenol sulfotransferase (SULT1A1) by quercetin in human adult and foetal livers. Xenobiotica 32:363\u2013368. https:\/\/doi.org\/10.1080\/00498250110119108","journal-title":"Xenobiotica"},{"key":"4194_CR40","doi-asserted-by":"publisher","unstructured":"Zhang M et al (2026) Polyethylene glycol 400 improves the bioavailability and anti-inflammatory activity of quercetin by modulating metabolic enzymes and efflux transporters. Int J Pharm 127302. https:\/\/doi.org\/10.1016\/j.ijpharm.2026.127302","DOI":"10.1016\/j.ijpharm.2026.127302"},{"key":"4194_CR41","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1124\/dmd.30.11.1266","volume":"30","author":"JA Williams","year":"2002","unstructured":"Williams JA, Ring BJ, Cantrell VE, Campanale K, Jones DR, Hall SD, Wrighton SA (2002) Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes. Drug Metab Dispos 30:1266\u20131273. https:\/\/doi.org\/10.1124\/dmd.30.11.1266","journal-title":"Drug Metab Dispos"},{"key":"4194_CR42","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.jnutbio.2009.09.001","volume":"21","author":"CC Wong","year":"2010","unstructured":"Wong CC, Meinl W, Glatt HR, Barron D, Stalmach A, Steiling H, Crozier A, Williamson G (2010) In vitro and in vivo conjugation of dietary hydroxycinnamic acids by UDP-glucuronosyltransferases and sulfotransferases in humans. J Nutr Biochem 21:1060\u20131068. https:\/\/doi.org\/10.1016\/j.jnutbio.2009.09.001","journal-title":"J Nutr Biochem"},{"key":"4194_CR43","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/j.1440-1681.2009.05158.x","volume":"36","author":"Y Chen","year":"2009","unstructured":"Chen Y, Xiao P, Ou-Yang DS, Fan L, Guo D, Wang YN, Han Y, Tu JH, Zhou G, Huang YF, Zhou HH (2009) Simultaneous action of the flavonoid quercetin on cytochrome P450 (CYP) 1A2, CYP2A6, N-acetyltransferase and xanthine oxidase activity in healthy volunteers. Clin Exp Pharmacol Physiol 36:828\u2013833. https:\/\/doi.org\/10.1111\/j.1440-1681.2009.05158.x","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"4194_CR44","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.bcp.2008.05.020","volume":"77","author":"C K\u00f6hle","year":"2009","unstructured":"K\u00f6hle C, Bock KW (2009) Coordinate regulation of human drug-metabolizing enzymes, and conjugate transporters by the Ah receptor, pregnane X receptor and constitutive androstane receptor. Biochem Pharmacol 77:689\u2013699. https:\/\/doi.org\/10.1016\/j.bcp.2008.05.020","journal-title":"Biochem Pharmacol"},{"key":"4194_CR45","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1515\/mr-2022-0032","volume":"2","author":"J Wang","year":"2022","unstructured":"Wang J, Lu P, Xie W (2022) Atypical functions of xenobiotic receptors in lipid and glucose metabolism. Med Rev 2:611\u2013624. https:\/\/doi.org\/10.1515\/mr-2022-0032","journal-title":"Med Rev"},{"key":"4194_CR46","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.3390\/cells12232752","volume":"12","author":"L Rakateli","year":"2023","unstructured":"Rakateli L, van der Huchzermeier R (2023) AhR, PXR and CAR: from xenobiotic receptors to metabolic sensors. Cells 12:2752. https:\/\/doi.org\/10.3390\/cells12232752","journal-title":"Cells"},{"key":"4194_CR47","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1211\/0022357056299","volume":"57","author":"Y Wang","year":"2005","unstructured":"Wang Y, Cao J, Zeng S (2005) Involvement of P-glycoprotein in regulating cellular levels of Ginkgo flavonols: quercetin, kaempferol, and isorhamnetin. J Pharm Pharmacol 57:751\u2013758. https:\/\/doi.org\/10.1211\/0022357056299","journal-title":"J Pharm Pharmacol"},{"key":"4194_CR48","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ejps.2005.03.001","volume":"25","author":"M Ofer","year":"2005","unstructured":"Ofer M, Wolffram S, Koggel A, Spahn-Langguth H, Langguth P (2005) Modulation of drug transport by selected flavonoids: involvement of P-gp and OCT? Eur J Pharm Sci 25:263\u2013271. https:\/\/doi.org\/10.1016\/j.ejps.2005.03.001","journal-title":"Eur J Pharm Sci"},{"key":"4194_CR49","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1016\/j.foodchem.2012.12.021","volume":"138","author":"KW Tan","year":"2013","unstructured":"Tan KW, Li Y, Paxton JW, Birch NP, Scheepens A (2013) Identification of novel dietary phytochemicals inhibiting the efflux transporter breast cancer resistance protein (BCRP\/ABCG2). Food Chem 138:2267\u20132274. https:\/\/doi.org\/10.1016\/j.foodchem.2012.12.021","journal-title":"Food Chem"},{"key":"4194_CR50","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.foodchem.2018.12.006","volume":"279","author":"S Ravisankar","year":"2019","unstructured":"Ravisankar S, Agah S, Kim H, Talcott S, Wu C, Awika J (2019) Combined cereal and pulse flavonoids show enhanced bioavailability by downregulating phase II metabolism and ABC membrane transporter function in Caco-2 model. Food Chem 279:88\u201397. https:\/\/doi.org\/10.1016\/j.foodchem.2018.12.006","journal-title":"Food Chem"},{"key":"4194_CR51","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1080\/00498254.2021.1912438","volume":"51","author":"M Nishihara","year":"2021","unstructured":"Nishihara M, Ramsden D, Balani SK (2021) Evaluation of the drug\u2013drug interaction potential for trazpiroben (TAK-906), a D2\/D3 receptor antagonist for gastroparesis, towards cytochrome P450s and transporters. Xenobiotica 51:668\u2013679. https:\/\/doi.org\/10.1080\/00498254.2021.1912438","journal-title":"Xenobiotica"},{"key":"4194_CR52","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3109\/03639045.2012.693502","volume":"39","author":"VR Challa","year":"2013","unstructured":"Challa VR, Babu PR, Challa SR, Johnson B, Maheswari C (2013) Pharmacokinetic interaction study between quercetin and valsartan in rats and in vitro models. Drug Dev Ind Pharm 39:865\u2013872. https:\/\/doi.org\/10.3109\/03639045.2012.693502","journal-title":"Drug Dev Ind Pharm"},{"key":"4194_CR53","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1124\/dmd.110.035212","volume":"39","author":"G An","year":"2011","unstructured":"An G, Gallegos J, Morris ME (2011) The bioflavonoid kaempferol is an Abcg2 substrate and inhibits Abcg2-mediated quercetin efflux. Drug Metab Dispos 39:426\u2013432. https:\/\/doi.org\/10.1124\/dmd.110.035212","journal-title":"Drug Metab Dispos"},{"key":"4194_CR54","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1124\/mol.104.009753","volume":"67","author":"ALA Sesink","year":"2005","unstructured":"Sesink ALA, Arts ICW, de Boer VCJ, Breedveld P, Schellens JHM, Hollman PCH, Russel FGM (2005) Breast cancer resistance protein (Bcrp1\/Abcg2) limits net intestinal uptake of quercetin in rats by facilitating apical efflux of glucuronides. Mol Pharmacol 67:1999\u20132006. https:\/\/doi.org\/10.1124\/mol.104.009753","journal-title":"Mol Pharmacol"},{"key":"4194_CR55","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1016\/j.bcp.2010.08.008","volume":"80","author":"K Mandery","year":"2010","unstructured":"Mandery K, Bujok K, Schmidt I, Keiser M, Siegmund W, Balk B, K\u00f6nig J, Fromm MF, Glaeser H (2010) Influence of the flavonoids apigenin, kaempferol, and quercetin on the function of organic anion transporting polypeptides 1A2 and 2B1. Biochem Pharmacol 80:1746\u20131753. https:\/\/doi.org\/10.1016\/j.bcp.2010.08.008","journal-title":"Biochem Pharmacol"},{"key":"4194_CR56","doi-asserted-by":"publisher","first-page":"106740","DOI":"10.1016\/j.ejps.2024.106740","volume":"196","author":"H Kaci","year":"2024","unstructured":"Kaci H, Bakos \u00c9, Needs PW, Kroon PA, Valentov\u00e1 K, Po\u00f3r M, \u00d6zvegy-Laczka C (2024) The 2-aminoethyl diphenylborinate-based fluorescent method identifies quercetin and luteolin metabolites as substrates of organic anion transporting polypeptides, OATP1B1 and OATP2B1. Eur J Pharm Sci 196:106740. https:\/\/doi.org\/10.1016\/j.ejps.2024.106740","journal-title":"Eur J Pharm Sci"},{"key":"4194_CR57","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.bcp.2012.05.011","volume":"84","author":"CC Wong","year":"2012","unstructured":"Wong CC, Akiyama Y, Abe T, Lippiat JD, Orfila C, Williamson G (2012) Carrier-mediated transport of quercetin conjugates: involvement of organic anion transporters and organic anion transporting polypeptides. Biochem Pharmacol 84:564\u2013570. https:\/\/doi.org\/10.1016\/j.bcp.2012.05.011","journal-title":"Biochem Pharmacol"},{"key":"4194_CR58","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.bcp.2011.01.004","volume":"81","author":"CC Wong","year":"2011","unstructured":"Wong CC, Botting NP, Orfila C, Al-Maharik N, Williamson G (2011) Flavonoid conjugates interact with organic anion transporters (OATs) and attenuate cytotoxicity of adefovir mediated by organic anion transporter 1 (OAT1\/SLC22A6). Biochem Pharmacol 81:942\u2013949. https:\/\/doi.org\/10.1016\/j.bcp.2011.01.004","journal-title":"Biochem Pharmacol"},{"key":"4194_CR59","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/ptr.5978","volume":"32","author":"SK Bedada","year":"2018","unstructured":"Bedada SK, Neerati P (2018) Evaluation of the effect of quercetin treatment on CYP2C9 enzyme activity of diclofenac in healthy human volunteers. Phytother Res 32:305\u2013311. https:\/\/doi.org\/10.1002\/ptr.5978","journal-title":"Phytother Res"},{"key":"4194_CR60","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ejps.2014.01.003","volume":"61","author":"MA Nguyen","year":"2014","unstructured":"Nguyen MA, Staubach P, Wolffram S, Langguth P (2014) Effect of single-dose and short-term administration of quercetin on the pharmacokinetics of talinolol in humans\u2014implications for the evaluation of transporter-mediated flavonoid\u2013drug interactions. Eur J Pharm Sci 61:54\u201360. https:\/\/doi.org\/10.1016\/j.ejps.2014.01.003","journal-title":"Eur J Pharm Sci"},{"key":"4194_CR61","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1177\/0091270005278407","volume":"45","author":"KA Kim","year":"2005","unstructured":"Kim KA, Park PW, Kim HK, Ha JM, Park JY (2005) Effect of quercetin on the pharmacokinetics of rosiglitazone, a CYP2C8 substrate, in healthy subjects. J Clin Pharmacol 45:941\u2013946. https:\/\/doi.org\/10.1177\/0091270005278407","journal-title":"J Clin Pharmacol"},{"key":"4194_CR62","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1002\/jps.24500","volume":"104","author":"MA Nguyen","year":"2015","unstructured":"Nguyen MA, Staubach P, Wolffram S, Langguth P (2015) The influence of single-dose and short-term administration of quercetin on the pharmacokinetics of midazolam in humans. J Pharm Sci 104:3199\u20133207. https:\/\/doi.org\/10.1002\/jps.24500","journal-title":"J Pharm Sci"},{"key":"4194_CR63","doi-asserted-by":"publisher","first-page":"896","DOI":"10.3109\/00498254.2015.1132792","volume":"46","author":"FF Jia","year":"2016","unstructured":"Jia FF, Tan ZR, McLeod HL, Chen Y, Ou-Yang DS, Zhou HH (2016) Effects of quercetin on pharmacokinetics of cefprozil in Chinese-Han male volunteers. Xenobiotica 46:896\u2013900. https:\/\/doi.org\/10.3109\/00498254.2015.1132792","journal-title":"Xenobiotica"},{"key":"4194_CR64","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1046\/j.1365-2125.2002.01683.x","volume":"54","author":"L Henderson","year":"2002","unstructured":"Henderson L, Yue QY, Bergquist C, Gerden B, Arlett P (2002) St John\u2019s wort (Hypericum perforatum): drug interactions and clinical outcomes. Br J Clin Pharmacol 54:349\u2013356. https:\/\/doi.org\/10.1046\/j.1365-2125.2002.01683.x","journal-title":"Br J Clin Pharmacol"},{"key":"4194_CR65","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.bbrc.2006.05.198","volume":"346","author":"F Perez-Vizcaino","year":"2006","unstructured":"Perez-Vizcaino F, Bishop-Bailley D, Lodi F, Duarte J, Cogolludo A, Moreno L, Bosca L, Mitchell JA, Warner TD (2006) The flavonoid quercetin induces apoptosis and inhibits JNK activation in intimal vascular smooth muscle cells. Biochem Biophys Res Commun 346:919\u2013925. https:\/\/doi.org\/10.1016\/j.bbrc.2006.05.198","journal-title":"Biochem Biophys Res Commun"},{"key":"4194_CR66","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1080\/17460441.2023.2241366","volume":"18","author":"SR Alizadeh","year":"2023","unstructured":"Alizadeh SR, Savadkouhi N, Ebrahimzadeh MA (2023) Drug design strategies that aim to improve the low solubility and poor bioavailability conundrum in quercetin derivatives. Expert Opin Drug Discov 18:1117\u20131132. https:\/\/doi.org\/10.1080\/17460441.2023.2241366","journal-title":"Expert Opin Drug Discov"},{"key":"4194_CR67","doi-asserted-by":"publisher","first-page":"6701","DOI":"10.2147\/IJN.S509877","volume":"20","author":"XR Li","year":"2025","unstructured":"Li XR, Qi L, Zhang XW, Wei C, Yu B, Pei TL (2025) Quercetin and nano-derivatives: potential and challenges in cancer therapy. Int J Nanomed 20:6701\u20136720. https:\/\/doi.org\/10.2147\/IJN.S509877","journal-title":"Int J Nanomed"},{"key":"4194_CR68","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3390\/pharmaceutics12111049","volume":"12","author":"I Loisios-Konstantinidis","year":"2020","unstructured":"Loisios-Konstantinidis I, Cristofoletti R, Jamei M, Turner D, Dressman J (2020) Physiologically based pharmacokinetic\/pharmacodynamic modeling to predict the impact of CYP2C9 genetic polymorphisms, co-medication and formulation on the pharmacokinetics and pharmacodynamics of flurbiprofen. Pharmaceutics 12:1049. https:\/\/doi.org\/10.3390\/pharmaceutics12111049","journal-title":"Pharmaceutics"},{"key":"4194_CR69","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.3390\/pharmaceutics14071474","volume":"14","author":"LM Fuhr","year":"2022","unstructured":"Fuhr LM, Marok FZ, Mees M, Mahfoud F, Selzer D, Lehr T (2022) A physiologically based pharmacokinetic and pharmacodynamic model of the CYP3A4 substrate felodipine for drug\u2013drug interaction modeling. Pharmaceutics 14:1474. https:\/\/doi.org\/10.3390\/pharmaceutics14071474","journal-title":"Pharmaceutics"},{"key":"4194_CR70","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1079\/BJN20061809","volume":"96","author":"W Mullen","year":"2006","unstructured":"Mullen W, Edwards CA, Crozier A (2006) Absorption, excretion and metabolite profiling of methyl-, glucuronyl-, glucosyl- and sulpho-conjugates of quercetin in human plasma and urine after ingestion of onions. Br J Nutr 96:107\u2013116. https:\/\/doi.org\/10.1079\/BJN20061809","journal-title":"Br J Nutr"},{"key":"4194_CR71","doi-asserted-by":"publisher","first-page":"1700447","DOI":"10.1002\/mnfr.201700447","volume":"62","author":"S Andres","year":"2018","unstructured":"Andres S, Pevny S, Ziegenhagen R, Bakhiya N, Sch\u00e4fer B, Hirsch-Ernst KI, Lampen A (2018) Safety aspects of the use of quercetin as a dietary supplement. Mol Nutr Food Res 62:1700447. https:\/\/doi.org\/10.1002\/mnfr.201700447","journal-title":"Mol Nutr Food Res"},{"key":"4194_CR72","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1182\/blood-2018-06-848747","volume":"132","author":"SR Vazquez","year":"2018","unstructured":"Vazquez SR (2018) Drug-drug interactions in an era of multiple anticoagulants: a focus on clinically relevant drug interactions. Blood 132:2230\u20132239. https:\/\/doi.org\/10.1182\/blood-2018-06-848747","journal-title":"Blood"},{"key":"4194_CR73","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/ptr.6503","volume":"34","author":"RB Pingili","year":"2020","unstructured":"Pingili RB, Challa SR, Pawar AK, Toleti V, Kodali T, Koppula S (2020) A systematic review on hepatoprotective activity of quercetin against various drugs and toxic agents: evidence from preclinical studies. Phytother Res 34:5\u201332. https:\/\/doi.org\/10.1002\/ptr.6503","journal-title":"Phytother Res"},{"key":"4194_CR74","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1039\/C4FO01178C","volume":"6","author":"K Kawabata","year":"2015","unstructured":"Kawabata K, Mukai R, Ishisaka A (2015) Quercetin and related polyphenols: new insights and implications for their bioactivity and bioavailability. Food Funct 6:1399\u20131417. https:\/\/doi.org\/10.1039\/C4FO01178C","journal-title":"Food Funct"},{"key":"4194_CR75","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.bcp.2017.03.021","volume":"139","author":"J Terao","year":"2017","unstructured":"Terao J (2017) Factors modulating bioavailability of quercetin-related flavonoids and the consequences of their vascular function. Biochem Pharmacol 139:15\u201323. https:\/\/doi.org\/10.1016\/j.bcp.2017.03.021","journal-title":"Biochem Pharmacol"},{"key":"4194_CR76","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13020-025-01156-4","volume":"20","author":"X Duan","year":"2025","unstructured":"Duan X et al (2025) Herb-drug interactions in oncology: pharmacodynamic\/pharmacokinetic mechanisms and risk prediction. Chin Med 20:107. https:\/\/doi.org\/10.1186\/s13020-025-01156-4","journal-title":"Chin Med"},{"key":"4194_CR77","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3109\/03602532.2014.882353","volume":"46","author":"B D\u00f6ring","year":"2014","unstructured":"D\u00f6ring B, Petzinger E (2014) Phase 0 and phase III transport in various organs: combined concept of phases in xenobiotic transport and metabolism. Drug Metab Rev 46:261\u2013282. https:\/\/doi.org\/10.3109\/03602532.2014.882353","journal-title":"Drug Metab Rev"},{"key":"4194_CR78","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1093\/jn\/138.9.1615","volume":"138","author":"S Egert","year":"2008","unstructured":"Egert S, Wolffram S, Bosy-Westphal A, Boesch-Saadatmandi C, Wagner AE, Frank J, Rimbach G, Mueller MJ (2008) Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans. J Nutr 138:1615\u20131621. https:\/\/doi.org\/10.1093\/jn\/138.9.1615","journal-title":"J Nutr"},{"key":"4194_CR79","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1177\/0091270011406278","volume":"52","author":"KM Duan","year":"2012","unstructured":"Duan KM, Wang SY, Ouyang W, Mao YM, Yang LJ (2012) Effect of quercetin on CYP3A activity in Chinese healthy participants. J Clin Pharmacol 52:940\u2013946. https:\/\/doi.org\/10.1177\/0091270011406278","journal-title":"J Clin Pharmacol"},{"key":"4194_CR80","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/bdd.605","volume":"29","author":"YJ Moon","year":"2008","unstructured":"Moon YJ, Wang L, DiCenzo R, Morris ME (2008) Quercetin pharmacokinetics in humans. Biopharm Drug Dispos 29:205\u2013217. https:\/\/doi.org\/10.1002\/bdd.605","journal-title":"Biopharm Drug Dispos"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04194-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-026-04194-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04194-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:45:04Z","timestamp":1790984704000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-026-04194-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,3]]},"references-count":80,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["4194"],"URL":"https:\/\/doi.org\/10.1007\/s00228-026-04194-5","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,3]]},"assertion":[{"value":"17 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This manuscript is a review of previously published literature and does not involve original studies with human participants, human tissues, identifiable personal data, or animals conducted by the authors. Therefore, ethics committee approval and informed consent to participate were not required.","order":1,"name":"Ethics","label":"Ethics and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing financial or non-financial interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"263"}}